AGORACOM Small-cap Investor Relations Blog

Agoracom Blog

Marble $MRBL.ca $MRBLF Launches its ‘MyMarble’ Financial Wellness Platform with Canada Finances $CTZ.ca $MOS.ca $MOGO.ca

Posted by AGORACOM at 11:30 AM on Thursday, March 18th, 2021

Vancouver, B.C. – March 18, 2021 – Marble Financial Inc. (C NSX :MRBL. CN) ( OTC:MRBLF ) ( FSE:2V0) (“Marble” or the “Company”) utilizes AI-driven financial technology company to help Canadians better understand how credit can affect their financial future, is pleased to announce a referral agreement with LSEO Canada Digital Marketing (“Canada Finances”) offering its consumers our AI-driven financial wellness SAAS platform, MyMarble.

Marble, a leading financial technology innovator, is expanding its referral program with Canada Finances, a company that aims to solve the problem of asymmetric information and put Canadian’s back in the driver’s seat. Since launching in August 2020, Canada Finances already attracts over 20,000 Canadians looking to obtain vehicle financing each month. Access to a motivated visitor base of consumers heavily focused on their financial goals presents another new growth channel of opportunity for Marble and further empowers Canadians using its complete personal finance fintech solution that supplies precise expert curated recommendations, insights, and financial literacy.

According to Thomas Feltmare, a senior economist for TD Economics, Canadian auto sales are expected to surge 37 percent in 2021 (1). This increase will result in thousands of consumers turning to alternative online financing options like Canada Finances to gain a more flexible and transparent service to achieve their financial goal of vehicle ownership. This growing trend amongst consumers has presented a much higher need for Canadians to use technology like MyMarble to strengthen their approval chances.

For consumers to receive the best offers and financing rates in a much shorter time period, this new referral engagement will leverage Canada Finance’s customer-centric and automated technology that accurately identifies consumers who require help from MyMarble financial wellness products. This engagement will enable thousands of monthly visitors to Canada Finances access to MyMarble’s platform, offering AI-powered recommendations, credit monitoring, coaching and budgeting technology to consistently boost their credit score.

Tags: 2V0, Canada Finances, Canadian Financial, Marble, Marble Financial, MRBL, MRBLF, MyMarble
Posted in Marble Financial Inc. | Comments Off on Marble $MRBL.ca $MRBLF Launches its ‘MyMarble’ Financial Wellness Platform with Canada Finances $CTZ.ca $MOS.ca $MOGO.ca

Loop Insights $MTRX $RACMF Enters Into Five-Store Pilot Agreement With Sobeys, Canada’s Second-Largest Grocer, To Deliver Digital Receipts Via Loop’s Wallet Pass Technology $AT.ca $QTRH.ca $SNSR $BSQR $PTS.ca

Posted by AGORACOM-JC at 8:37 AM on Thursday, March 18th, 2021

https://miro.medium.com/max/3150/1*f9msDHyceA_TbRM30jQhsw.png

Company has entered into a five-store pilot with Sobeys, Canada’s second-largest grocer, to provide Sobeys with Loop’s Insights and Engage platforms, including its new digital receipt capability, as well as Loop’s Wallet pass technology.

VANCOUVER, British Columbia, March 18, 2021 — Loop Insights Inc. (MTRX:TSXV RACMF:OTCQB) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, is pleased to announce the Company has entered into a five-store pilot with Sobeys, Canada’s second-largest grocer, to provide Sobeys with Loop’s Insights and Engage platforms, including its new digital receipt capability, as well as Loop’s Wallet pass technology.

Sobeys SVP and Chief Information Officer Bruce Burrows stated: “Loop Insights’ diverse suite of services was an obvious fit for Sobeys as we look to drive consumer engagement and close gaps in our personalization of the customer experience. By testing Loop’s Fobi device in our retail operations, we hope to connect more directly with customers while returning AI-driven insights to optimize our retail operations.”

Loop Insights CEO Rob Anson stated: “Signing this five-store pilot agreement with Sobeys, which generates over $28 Billion in annual sales from more than 1,400 stores under various banners across Canada, is another clear indication of the power of Loop’s enterprise-level services, including Engage, Insights and our Wallet pass technology. Following our LOI to acquire Passcreator, we now have complete control of our technology, which will allow for customized, large-scale implementations for our clients.”

Under the terms of the agreement, the Company will deploy its Fobi device at five select Sobeys locations in order to pilot the onboarding of shoppers to receive electronic receipts.

Should the pilot program achieve its desired results, the parties may expand the scope of the relationship to additional Sobeys locations.

This Press Release Is Available On The Loop Insights Verified Forum On AGORACOM For Shareholder Discussion And Management Engagement https://agoracom.com/ir/LoopInsights/forums/discussion

Read More: https://agoracom.com/ir/LoopInsights/forums/discussion/topics/757560-loop-insights-enters-into-five-store-pilot-agreement-with-sobeys-canada-s-second-largest-grocer-to-deliver-digital-receipts-via-loop-s-wallet-pass/messages/2308731#message

Tags: AI, Amazon, artificial intelligence, Big data, Bitcoin, covid19, NCAA, NCAA Big West Conference, small cap
Posted in Loop Insights Inc. | Comments Off on Loop Insights $MTRX $RACMF Enters Into Five-Store Pilot Agreement With Sobeys, Canada’s Second-Largest Grocer, To Deliver Digital Receipts Via Loop’s Wallet Pass Technology $AT.ca $QTRH.ca $SNSR $BSQR $PTS.ca

XPhyto Therapeutics $XPHY.ca $XPHYF Announces European Approval for 25 Minute COVID-19 PCR Test $NGM.ca $SONA.ca $HBP.ca $MIR.ca $IPA.ca

Posted by AGORACOM at 8:35 AM on Thursday, March 18th, 2021

This image has an empty alt attribute; its file name is XPHYTO-70-x-70.jpg

CE Mark received for in vitro diagnostic (IVD) test for the detection of SARS-CoV-2
Rapid results with ease of use – single 20-minute PCR cycle plus 5-minute detection process
High sensitivity – 104.73 c/PCR limit of detection with 95% confidence interval
High specificity – zero cross-reactivity on 19x respiratory infectious disease panel
High robustness – no impact on results from minor changes in process parameters
100% repeatability and laboratory precision observed
Sales launch in Europe planned for April 2021

XPhyto Therapeutics Corp. (CSE:XPHY)(OTC:XPHYF)(FSE:4XT) (“XPhyto” or the “Company”), and its exclusive German diagnostics development partner, 3a-diagnostics GmbH (“3a”), are pleased to announce the European approval of its point-of-care SARS-CoV-2 (COVID-19) RT-PCR test system (“Covid-ID Lab”). Covid-ID Lab is now registered within the European Union as a commercial in vitro diagnostic (CE-IVD) test.

“Our test is one of the fastest PCR-based COVID-19 tests currently approved. With a sample collection to result time of 25 minutes, Covid-ID Lab combines the speed of a rapid screening test with the accuracy of a PCR diagnostic,” said Hugh Rogers, CEO and Director of XPhyto. “Covid-ID Lab is designed for point-of-care testing, particularly in satellite and small-scale labs, such as transportation hubs, borders, care facilities, schools, pharmacies, and hospitality settings.”

Covid-ID Lab is a multiplex viral RNA probe kit based on the reverse transcriptase-polymerase chain reaction (RT-PCR) method. For assay performance, Covid-ID Lab requires only a single 20-minute PCR thermal cycle without prior RNA extraction as part of the sample preparation. Many widely available standard PCR instruments are suitable to run the test. Results are collected after the PCR cycle via easy-to-read optical indicator strips on a simple fluidics platform. The elimination of RNA extraction for sample preparation reduces the risk of cross-contamination and minimizes the need for lab materials and trained personnel. The rapid results, minimal laboratory equipment, and ease of use are expected to translate into reduced operating costs, greater convenience and portability.

During validation of the assay, the limit of detection for SARS-CoV-2 RNA was determined to be 104.73 c/PCR within a 95% confidence interval. Specificity of 100% against 19 other pathogens of serious respiratory infections was demonstrated on a respiratory verification panel. Precision was determined through evaluation of variance of the analysis results due to random deviations, a repeatability/intra-assay precision evaluation (same lab, user, equipment, etc.), and a laboratory precision evaluation (different lab, user, equipment, etc.). Robustness was measured by evaluation of the impact of minor changes on process parameters (transport medium, PCR cycler model, ramp rate, template volume, hybridization mixing ratio, etc.). The validation studies were carried out accordingly to ICH Q2 (R1) Validation of Analytical Procedures: Text and Methodology and VQ-015 Validation of Methods, European Medicines Agency. The quality management system was in accordance with EN ISO 13485: 2016 and EN ISO 9001: 2015.

Tags: Bioscience, covid, covid19, Delivery, Drug, Healthcare, Mescaline, Opportunities, Oral, psychedelics, Rapid
Posted in All Recent Posts, Xphyto Therapeutics | Comments Off on XPhyto Therapeutics $XPHY.ca $XPHYF Announces European Approval for 25 Minute COVID-19 PCR Test $NGM.ca $SONA.ca $HBP.ca $MIR.ca $IPA.ca

Candente Copper $DNT.ca Engages Yaku for Environmental Assessment and Protection at Canariaco Copper Deposit $FCX.ca $TECK.ca $FSUGY $PER.ca

Posted by AGORACOM at 8:29 AM on Thursday, March 18th, 2021

http://blog.agoracom.com/wp-content/uploads/2020/08/candente-copper-for-blog1.jpg

Engaged to conduct and continue previous baseline studies at the Cañariaco Project
9B lbs copper, 2M oz gold and 54M oz silver in: Measured and Indicated Resources

Candente Copper Corp. (TSX: DNT, BVL: DNT) (“Candente Copper”, “the Company”) is pleased to announce that Yaku Consultores (“Yaku”) has been engaged to conduct and continue previous baseline studies at the Cañariaco Project located in Northern Peru. The work will be part of environmental impact studies and habitat protection for all exploration phases of permitting including drilling and also for the community and regional stakeholders.

“We are excited to be moving the Cañariaco project forward with Yaku’s environmental work and new engineering studies underway by Ausenco. Timing couldn’t be better as Cañariaco has been identified by both Goldman Sachs and Deutche Bank as one of the top copper projects needed to supply the upcoming supply-demand shortage for copper,” says Joanne Freeze, President and CEO, Candente Copper.

Yaku is comprised of a team of highly experienced professionals focused on providing quality environmental and social consulting services. These services contribute to the sustainable development of the environment and exceed regulations.

Candente Copper has recently obtained the respective authorizations from SERFOR and PRODUCE (Peruvian authorities for National Forest and Wildlife Services and the Ministry of Production) to conduct new monitoring of Water Quality, Air Quality, Noise Levels and Biology, Wild Flora and Fauna and Hydrobiology. Yaku has begun collecting new data within the project area which will add significantly to the studies that Candente Copper has been conducting such since 2004.

Given the difficult situation for the community with the COVID-19 epidemic, the company is also collaborating with local health facilities to assist in the protection and care of citizens in the area surrounding Cañariaco. To date, the Company has assisted with PPE supplies and the operation of emergency health equipment.

About Candente Copper

Candente Copper is a mineral exploration company engaged in the acquisition, exploration, and development of mineral properties. The Company is currently focused on its 100% owned Cañariaco project, which includes the Feasibility stage Cañariaco Norte deposit as well as the Cañariaco Sur deposit and Quebrada Verde prospect, located within the western Cordillera of the Peruvian Andes in the Department of Lambayeque in Northern Peru.

Please see https://www.candentecopper.com/investors/presentations for details from previous resource and engineering studies which delineated 9B lbs copper, 2M oz gold and 54M oz silver in: Measured and Indicated Resources of 752.4 million tonnes grading 0.45% copper, 0.07 grams per tonne (“g/t”) gold and 1.9 g/t silver (0.52% Cu equivalent) containing 7.533 B lb Cu, 1.67 M oz Au and 45.24 M oz Ag and Inferred Resources of 157.7 million tonnes grading 0.44% copper, 0.06 g/t gold and 1.8 g/t silver containing 1.434 B lb Cu, 0.3M oz Au and 8.932 M oz Ag.

Tags: #Canariaco, #copper, #Fortesque, #Freeport, #Gold, #GoldmanSachs, #JointVenture, #mining
Posted in All Recent Posts, Candente Copper | Comments Off on Candente Copper $DNT.ca Engages Yaku for Environmental Assessment and Protection at Canariaco Copper Deposit $FCX.ca $TECK.ca $FSUGY $PER.ca

@Novamind_Inc $NM.ca $NVMDF Partners with Merck $MRK for New Treatment-Resistant Depression Trial $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

Posted by AGORACOM-JC at 8:15 AM on Thursday, March 18th, 2021

Novamind’s subsidiary, Cedar Clinical Research, to serve as a key clinical research site

TORONTO, ON / March 18, 2021 / Novamind Inc., (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) (“Novamind” or the “Company”), a leading mental health company specialized in psychedelic medicine, is pleased to announce that its wholly-owned subsidiary, Cedar Clinical Research (“CCR”) has been selected as a key research site for a clinical trial focused on treatment-resistant depression by Merck & Co., (“Merck”), a world-leading pharmaceutical company.

The phase II study will assess the efficacy and safety of a new Merck drug for treatment-resistant depression (TRD), a mental health condition that affects approximately 30% of people who suffer from major depressive disorder1. The study is titled “A Phase 2a, Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-1942 Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression.” The clinical trial begins enrolling individuals in March 2021.

“We’re proud to partner with Merck and support its innovative neuroscience work to develop a potential new drug for treatment-resistant depression,” said Dr. Reid Robison, Chief Medical Officer of Novamind and Principal Investigator at CCR. “CCR has unique expertise conducting clinical trials and research studies in neuropsychiatry, for a variety of sponsors. This exciting research opportunity with Merck exemplifies a growing pipeline of opportunities for us to provide contract research services to leading drug developers.”

The selection of Novamind’s Cedar Clinical Research for this significant study reflects its deep experience hosting phase I to phase IV clinical trials, many of them focused on psychedelic medicines, and emerging therapies in neuropsychiatry. CCR’s clinical trial expertise includes trial design, patient recruitment, and patient management for drug development sponsors including pharmaceutical companies, academic institutions and non-profit groups.

Yaron Conforti, CEO and Director of Novamind said: “Under Dr. Robison’s leadership, Cedar Clinical Research has proven itself as a best-in-class research site for emerging mental health therapeutics. We’re excited to work with Merck, a world-class pharmaceutical company, to advance research for innovative mental health treatments.”

Cedar Clinical Research is currently contracted for seven clinical trials with various sponsors, in addition to its ongoing contributions to numerous clinical trials for psychedelic medicine, including most notably the MAPS-sponsored phase II clinical trial of MDMA-assisted psychotherapy for eating disorders, a ketamine-assisted psychotherapy study (KAP) for end-of-life palliative care with the Ketamine Research Foundation, and a ketamine study to treat suicidal ideation in partnership with the University of Texas, Austin. CCR became widely known for its work in psychedelic medicine following Dr. Robison’s role as a Principal Investigator in Utah for a clinical trial that led to the first approval of Janssen’s Spravato™ in March 2019.

To learn more about the Merck study with Cedar Clinical Research, please visit this link.

About Novamind

Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Both Cedar Psychiatry and Cedar Clinical Research are wholly-owned subsidiaries of Novamind. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit www.novamind.ca.

Contact Information

Novamind

Yaron Conforti, CEO and Director
Telephone: +1 (647) 953 9512
Bill Mitoulas, Investor Relations
Email: [email protected]

Forward-Looking Statements

This news release contains forward-looking statements. All statements other than statements of historical fact included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations including the risks detailed from time to time in the Company’s public disclosure. The reader is cautioned not to place undue reliance on any forward-looking information. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable laws.

1 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982454/#!po=0.537634

SOURCE: Novamind Inc.

Tags: COMPASS PATHWAYS, CSE, Field Trip Health Ltd., MIND MEDICINE (MINDMED) INC
Posted in Novamind Inc. | Comments Off on @Novamind_Inc $NM.ca $NVMDF Partners with Merck $MRK for New Treatment-Resistant Depression Trial $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

VIDEO – KWESST $KWE.ca $KWEMF Hits A Key Milestone In The Digitization of The Modern Army $WRTC $BYRN.ca $PAT.ca $POWW

Posted by AGORACOM-JC at 4:10 PM on Wednesday, March 17th, 2021

If you haven’t heard of KWESST Micro Systems (KWE:TSXV) you’re not alone because the Company just listed for trading a couple of months ago – and it is probably the coolest new listing of 2020 if you love high-tech, covert defense systems that we only get to see in Tom Cruise movies.

KWESST is a leader in “soldier systems” which are technologies that increase the capabilities of soldiers, Let’s be clear right off the start, KWESST doesn’t sell weaponry. Rather, it sells technologies that make a big difference to the safety and effectiveness of soldiers.

For example, out in a field of combat, soldiers emit Electro Magnetic (EM) signatures that make them detectable by enemy combatants. KWESST has a battlefield decoy system that creates multiple false phantom signatures to spoof adversaries. This picture is worth 1,000 words.

Or perhaps the “TASCS” – Tactical Awareness and Situational Control System

An App and snap-on weapon adaptor that enables real-time streaming of situational awareness data of any kind from any source, including drones, direct to smart display devices and operational assets, for a common operating picture and networked engagement.

The company successfully achieved an important milestone under the contract announced in December 2020 for a key military customer.

This milestone entailed the integration of the Company’s TASCS IFM (Integrated Fires Module) for the 81mm Mortar Fire Control System into the Android Tactical Assault Kit (ATAK), the preeminent battlefield management system for NATO countries . As a result, the Company will now proceed to the next phase of the contract, involving live-fire trials at various U.S. military bases.

A world-first in digitizing the function of a mortar team, from the identification of the target to the aiming of the mortar.

We could go on about many other such technologies created by KWESST but this is AGORACOM after all and we want to get down to the business of KWESST, the highlights of which are as follows:

A developer of next-generation systems for forces around the world, including those of NATO and its allies
A leadership team whose experience spans decades and hundreds of millions of dollars in military and homeland security contracts
A sales and distribution network of agents that spans the globe
Partnerships with globally recognized OEM’s, including Samsung
Received a follow-on order for $1.1 Million from a key US Military Customer.

And last but not least, a secret weapon in its Executive Chairman David Luxton, whose companies under his leadership have generated over $1,000,000,000 (Yes, BILLION).

The soldier systems market is projected to hit $14.5 Billion by 2023 and, up until now, small cap investors have never had a company to participate in this lucrative (and SUPER COOL) market.

Tags: CSE, defense stocks, General (Retired) Rick Hillier, investing, military, Samsung
Posted in AGORACOM Via Satellite, All Recent Posts, Featured, KWESST Micro Systems Inc. | Comments Off on VIDEO – KWESST $KWE.ca $KWEMF Hits A Key Milestone In The Digitization of The Modern Army $WRTC $BYRN.ca $PAT.ca $POWW

CLIENT FEATURE: $HOLL $HSTRF Powering Class-leading #Cannabis Products From Seed to Shelf $CRON $GTBIF $INDS $META.ca $FAF.ca $WEED.ca

Posted by AGORACOM at 2:46 PM on Wednesday, March 17th, 2021

CLIENT FEATURE: Hollister Biosciences Inc. (HOLL: CSE) – Acquiring, developing and powering class-leading cannabis consumer products.

WHY HOLLISTER?

Vertically integrated, high-margin cannabis company with high-quality cannabis and hemp products in over 280 dispensaries throughout California and over 90 dispensaries throughout Arizona, plus joint ventures, licensing agreements, and partnerships with global brands.
Hollister controls the whole process from manufacturing to sales, to distribution. From seed to shelf.
Fully licensed and compliant and have established a statewide distribution within California for medical and recreational cannabis.
The U.S. market for cannabis-infused drinks is expected to grow to $1.4 billion by 2024. Zenith Global.
The market for hemp-derived CBD products was USD $591 Million in 2018, expected to reach USD $22 Billion by 2022.

Recent Highlights:

Q4 2020 Financial Highlights:

Q4 2020 Performance Includes CDN $14.93 Million in Revenue With an Estimated CDN $2.53 Million in EBITDA a YoY Revenue Increase of 3215% from Q4 2019

March:

Hollister’s direct-to-consumer delivery platform, Dreamy Delivery, will be the official delivery platform of the 2021 Emerald Cup Awards.
- The Emerald Cup Awards have been the premier Cannabis Cup in California for 17 years.
Hollister Biosciences Inc. Announces Closing of $7.9M Private Placement of Special Warrants, Including Full Exercise of Agents’ Option

February:

Stock Hits ALL-TIME High

January

Hollister $HOLL.ca $HSTRF Reported Record Q4 Revenues of CAD $14.93M From 370 Dispensaries In California and Arizona
INDUSTRY BULLETIN: Cannabis In California Will Boom Into A Powerhouse Opportunity
Announces $6.5m Private Placement

December:

Hollister Biosciences 100% Owned Subsidiary Venom Extracts Achieves Final $40 Million Revenue Milestone

Market Analysis/Overview:

What is Hollister?

Hollister Biosciences Inc. is a multi-state company with a portfolio of innovative, high-quality cannabis & hemp branded consumer products and white-labelling manufacturing. Products are sold in 370 dispensaries across Arizona and California.
Hollister Biosciences owns 100% of Venom Extracts, a category-leading brand that sold over 4 million grams in 2020, accounting for up to 30 percent of category sales in Arizona.
Products from Hollister Biosciences Inc. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with concentrates (shatter, budder, crumble), distillates, solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures.
The wholly-owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker”.

What Brands Does Hollister Own?

Hollister $HOLL.ca $HSTRF

$CRON $GTBIF $INDS $META.ca $FAF.ca $WEED.ca

Hollister Biosciences Inc. is traded on the CSE as HOLL.

For more information, visit: https://hollisterbiosciences.co/investors/

FULL DISCLOSURE: Hollister Biosciences Inc. is an advertising client of AGORA Internet Relations Corp.

Tags: Aphria Inc, Arizona, Aurora Cannabis Inc, california cannabis, Cannabis, Canopy Growth Corp, CBD, Cronos Group Inc
Posted in Hollister Biosciences | Comments Off on CLIENT FEATURE: $HOLL $HSTRF Powering Class-leading #Cannabis Products From Seed to Shelf $CRON $GTBIF $INDS $META.ca $FAF.ca $WEED.ca

Maitri Health Technologies $MTEC.ca Announces Health Canada Approval of Domestically Manufactured N95 Masks $DOC.ca $DOCRF $WELL.ca $PRN.ca

Posted by AGORACOM at 10:13 AM on Wednesday, March 17th, 2021

Medical-grade protective gear designed and made in Canada ;
Offers greater certainty regarding source, quality and timely delivery of genuine N95 masks.

VANCOUVER, BC , March 17, 2021 /CNW/ – Maitri Health Technologies Corp. (“Maitri”) (CSE: MTEC) (FRA: D84), a global platform for healthcare supply security, today announced the availability of N95 medical-grade protective masks, one of the few, domestically manufactured N95 masks to receive Health Canada certification.

Health Canada Approved N95 Mask Offered By Maitri Health Technologies. (CNW Group/Maitri Health Technologies Corp.)

N95 masks are among the most in-demand and difficult to source pieces of personal protective equipment (PPE) commonly used by hospital, healthcare and other frontline workers. N95 masks filter out at least 95 per cent of very small particles, including airborne droplets.

Maitri’s N95 masks, manufactured in Port Coquitlam, B.C. through an exclusive partnership with INNO Lifecare, were approved by Health Canada in March.

“Maitri is delivering what governments and organizations across Canada have sorely needed and requested since the beginning of the pandemic – a domestically manufactured and certified N95 mask,” said Andrew Morton, CEO of Maitri.

Tags: Andrew Morton, COVID-19, Maitri, Maitri Health Technologies Corp., Maitri Health Techologies, MTEC, n95
Posted in Maitri Health Technologies Corp. | Comments Off on Maitri Health Technologies $MTEC.ca Announces Health Canada Approval of Domestically Manufactured N95 Masks $DOC.ca $DOCRF $WELL.ca $PRN.ca

$FANS.ca $FUNFF Announces Strategic Technology Partnership With $TGS.ca For Major Live Esports Events $DKNG $PENN $GAN $ESPO $AESE $EGLX.ca $BRAG.ca $FDM.ca $SCR.ca $BRAG.ca $TNA.ca $FDM.ca $JJ.ca

Posted by AGORACOM at 9:46 AM on Wednesday, March 17th, 2021

The partnership will launch prediction games for major live esports events
“The partnership with TGS Esports brings forth a new platform that will enable us to capture new opportunities within the fast-growing esports market,” said Scott Burton, CEO of FansUnite.

VANCOUVER, BC, March 17, 2021 /CNW/ – TGS Esports Inc. (“TGS” or the “Company”) (TSXV: TGS) (FRA: 5RH)) is pleased to announce that it has entered into a strategic partnership with FansUnite Entertainment Inc. (CSE: FANS) (OTCQB: FUNFF) (“FansUnite”), to launch live esports tournaments prediction games.

TGS livestream demo showcasing FansUnite’s stream prediction platform

TGS All New Prediction Game (CNW Group/TGS Esports Inc)

TGS partners with organizations and brands to build and grow their esports communities via tournaments, broadcast production and events. Through the partnership, FansUnite will incorporate its technology solutions into TGS events to establish a new prediction platform where live audience predictions can be placed on multiple outcomes within every white-label esports event run by TGS. Viewers can make live predictions during TGS events for which they can win prizes if their selections are correct.

Esports revenue in 2020 was over $1 billion[1], excluding revenues from betting. TGS has built white-label esports experiences for over 15 brands, interacting with over 200,000 gamers and by offering prediction games, TGS is able to increase the level of engagement between fans and brands.

Additionally, the prediction games from the platform will be featured on TGS’ Pepper Esports platform which will enable all tournament organizers to offer predictions and rivalry challenges in their tournaments to their viewers.

“Live predictions is a feature our brand partners have been asking us to implement for a long time.” said Spiro Khouri, CEO of TGS Esports Inc. “By implementing FansUnite’s technology into our esports events TGS is able to increase the level of engagement between fans and brands.”

“The partnership with TGS Esports brings forth a new platform that will enable us to capture new opportunities within the fast-growing esports market,” said Scott Burton, CEO of FansUnite. “TGS collaborates with numerous esports event organizers who have a large following of enthusiastic esports gamers who like to participate in their events. Our online betting solutions coupled with TGS esports platform will enable us to attract a new and widening audience from these events.”

For more information, click here.

Tags: Activision Blizzard, Allied Esports Entertainment Inc, Apple, Bragg Gaming Group Inc, CSE, Draftkings Inc, EA sports, eGambling, egaming, Enthusiast Gaming Holdings Inc, esports, esports betting, eSports Gambling, eSports Investing, video games
Posted in FansUnite Entertainment Inc., TGS ESports Inc. | Comments Off on $FANS.ca $FUNFF Announces Strategic Technology Partnership With $TGS.ca For Major Live Esports Events $DKNG $PENN $GAN $ESPO $AESE $EGLX.ca $BRAG.ca $FDM.ca $SCR.ca $BRAG.ca $TNA.ca $FDM.ca $JJ.ca